These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32774661)

  • 1. Beliefs and preferences regarding biological treatments for severe asthma.
    Bikov A; Oğuzülgen IK; Baiardini I; Contoli M; Emelyanov A; Fassio O; Ivancevich JC; Kaidashev I; Kowal K; Labor M; Lahousse L; Mihaicuta S; Novakova S; Padilla Galo A; Simidchiev A; Tiotiu A; Ansotegui IJ; Bernstein JA; Boulet LP; Canonica GW; Dubuske L; Rosario N; Santus P; Braido F;
    World Allergy Organ J; 2020 Jul; 13(7):100441. PubMed ID: 32774661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab for asthma in adults and children.
    Normansell R; Walker S; Milan SJ; Walters EH; Nair P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience.
    Kupryś-Lipińska I; Majak P; Molinska J; Kuna P
    BMC Pulm Med; 2016 Apr; 16(1):61. PubMed ID: 27117315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of biologicals in the treatment of adults with severe asthma - real-life experiences.
    Kotisalmi E; Hakulinen A; Mäkelä M; Toppila-Salmi S; Kauppi P
    Asthma Res Pract; 2020; 6():2. PubMed ID: 32467765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An online survey detected knowledge gaps and cost-saving opportunities in asthma maintenance treatment among allergists, pulmonologists, ENTs and primary care.
    Désirée LL; Margarita FV; Mónica RG; María Del Carmen CS; Jorge Agustín LP; José Antonio OM; Blanca DR; Erika Del Carmen LE; Jade RL; Juan Carlos VG; Jorge SP
    World Allergy Organ J; 2019 Dec; 12(12):100084. PubMed ID: 31768217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.
    Siergiejko Z; Świebocka E; Smith N; Peckitt C; Leo J; Peachey G; Maykut R
    Curr Med Res Opin; 2011 Nov; 27(11):2223-8. PubMed ID: 21933100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab versus Mepolizumab as add-on therapy in asthma patients not well controlled on at least an inhaled corticosteroid: A network meta-analysis.
    Nachef Z; Krishnan A; Mashtare T; Zhuang T; Mador MJ
    J Asthma; 2018 Jan; 55(1):89-100. PubMed ID: 28459601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
    Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
    Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM; Karner C; Mindus SM; Ferrara G
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.
    Pfeffer PE; Ali N; Murray R; Ulrik C; Tran TN; Maspero J; Peters M; Christoff GC; Sadatsafavi M; Torres-Duque CA; Altraja A; Lehtimäki L; Papadopoulos NG; Salvi S; Costello RW; Cushen B; Heffler E; Iwanaga T; Al-Ahmad M; Larenas-Linnemann D; Kuna P; Fonseca JA; Al-Lehebi R; Rhee CK; Perez-de-Llano L; Perng Steve DW; Mahboub B; Wang E; Goh C; Lyu J; Newell A; Alacqua M; Belevskiy AS; Bhutani M; Bjermer L; Bjornsdottir U; Bourdin A; Bulow AV; Busby J; Canonica GW; Cosio BG; Dorscheid DR; Muñoz-Esquerre M; FitzGerald JM; Gil EG; Gibson PG; Heaney LG; Hew M; Hilberg O; Hoyte F; Jackson DJ; Koh MS; Ko HB; Lee JH; Lehmann S; Chaves Loureiro C; Lúðvíksdóttir D; Menzies-Gow AN; Mitchell P; Papaioannou AI; Popov TA; Porsbjerg CM; Salameh L; Sirena C; Taillé C; Taube C; Tohda Y; Wechsler ME; Price DB
    Allergy; 2023 Jul; 78(7):1934-1948. PubMed ID: 36929509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Real-life" management of patients with severe asthma in the biologics era: Can we do better?
    Charriot J; Maravic M; Huguet M; Vachier I; Suehs C; Bourdin A
    World Allergy Organ J; 2021 Apr; 14(4):100528. PubMed ID: 33815653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
    Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD005307. PubMed ID: 19821344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of severe asthma patients on biologics: a real-life European registry study.
    Principe S; Richards LB; Hashimoto S; Kroes JA; Van Bragt JJMH; Vijverberg SJ; Sont JK; Scichilone N; Bieksiene K; Ten Brinke A; Csoma Z; Dahlén B; Gemicioglu B; Grisle I; Kuna P; Lazic Z; Mihaltan F; Popović-Grle S; Škrgat S; Marcon A; Caminati M; Djukanovic R; Porsbjerg C; Maitland Van Der Zee AH
    ERJ Open Res; 2023 Jul; 9(3):. PubMed ID: 37143845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.
    Kew KM; Dias S; Cates CJ
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data.
    Husereau D; Goodfield J; Leigh R; Borrelli R; Cloutier M; Gendron A
    Allergy Asthma Clin Immunol; 2018; 14():15. PubMed ID: 29713354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.